TCR² Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
USA Life Sciences Database,
CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR) (TCR2 or the Company), a clinical-stage…